breast cancer

Niosomal mefloquine and cisplatin in breastcancer: comparative effects on apoptosisand angiogenesis via in vitro and in silicoanalysis

🔬 Introduction Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide. Among its subtypes, Triple-Negative Breast Cancer (TNBC) is particularly aggressive due to the absence of estrogen, progesterone, and HER2 receptors, making targeted therapy challenging.Apoptosis resistance and enhanced angiogenesis are two major hallmarks of TNBC progression. Targeting both pathways simultaneously […]

Niosomal mefloquine and cisplatin in breastcancer: comparative effects on apoptosisand angiogenesis via in vitro and in silicoanalysis Read Post »

Liposome/AZIF-8 Janus nanoplatforms: Promising nanocarriers forimproving chemotherapeutic outcomes in breast cancer treatment

🔬 Introduction Researchers at Mashhad University of Medical Sciences have developed an innovative dual-delivery nanoplatform designed to enhance the effectiveness of chemotherapy in breast cancer. This novel Janus nanoparticle, combining AZIF-8 and liposomes, offers targeted, simultaneous delivery of both hydrophilic and hydrophobic drugs. 🧪What Makes This Nanoparticle Special? 🧫 Key Findings (In Vitro & In

Liposome/AZIF-8 Janus nanoplatforms: Promising nanocarriers forimproving chemotherapeutic outcomes in breast cancer treatment Read Post »

Scroll to Top